Shika Pappoe, MD, MPH, MBA, Regional Medical Officer, CareMore
Dr. Shika Pappoe is regional medical officer at CareMore Health System, which uses an innovative health care delivery approach that addresses health needs by focusing on prevention and highly coordinated care. In this role, Dr. Pappoe oversees care delivery in the Whittier region of CareMore's Southern California operations. She is responsible for overall patient care and clinical programs managed within the organization's care centers located in the Whittier region. Pappoe received her medical degree and her bachelor of science in molecular biophysics and biochemistry from Yale. She holds a master's degree in public health from Harvard University School of Public Health and is completing her MBA from the Wharton School at the University of Pennsylvania. She trained in internal medicine and nephrology at the Brigham and Women's Hospital and Harvard Medical School. Pappoe served as an assistant professor of clinical medicine at the Keck School of Medicine of the University of Southern California, and is board certified in internal medicine and nephrology.
Ali Khan, MD, MPP, FACP, Regional Medical Officer, CareMore
Ali Khan, MD, MPP, FACP serves CareMore Health System as a practicing internist and Regional Medical Officer for Northern California. There, he oversees clinical operations, quality and outcomes for CareMore's high-utilizer, vulnerable senior members across two counties in the Bay Area.
During his previous work at Iora Health, Dr. Khan served on the national clinical operations leadership team as Director of Physician Engagement and a clinical innovator in the strategic design and implementation of a variety of initiatives in population health, clinical quality improvement, clinical application product development and workforce development. A board-certified internist, Ali completed his residency at Yale-New Haven Hospital, where he serves on the clinical faculty. He is a graduate of the Harvard Kennedy School and VCU's Medical College of Virginia, earning joint MD and MPP degrees as a Harvard Public Service Fellow.
Beyond the clinic, Ali maintains an active public leadership portfolio, including recent service on the national boards of Doctors for America, the American College of Physicians, Physicians for Human Rights and Virginia Commonwealth University, and as Chair of ACP's National Council of Resident/Fellow Members. He currently serves on national advisory boards for Primary Care Progress, the California Healthcare Foundation and Costs of Care.
Gabrielle Sabatini, Director of Sales, OptimizeRx
Gabrielle Sabatini was recently promoted to Director of Sales at OptimizeRx. Gabrielle has worked at OptimizeRx since 2011 in both Account Management on the brand side, as well as, the founding Channel Manager supporting our EMR Partners. Gabby has be instrumental in launching and servicing some of the largest Pharma brand campaigns including Crestor, Cialis, Lipitor, Chantix, etc. She graduated from Western Michigan University with a Bachelor of Science in Interdisciplinary Health Services and a minor in Marketing. Gabrielle is a member of the Healthcare Business Women's Association.
Ed Berger, SVP of Marketing, OptimizeRx
Ed brings over 30 years of successful, in-depth pharmaceutical brand marketing experience working both on the client and agency services side of the business. He has been OptimizeRx's VP of Sales, where he played a pivotal role in acquiring major business accounts, including AstraZeneca, Otsuka, Novartis, Shire, and J&J.
Earlier in his career, Berger served in senior marketing roles at Stuart Pharmaceuticals, ICI Pharma and AstraZeneca Pharmaceuticals.
He has hands-on marketing experience working in several therapeutic categories, including cardiovascular, CNS, oncology, pain, anesthesia, infection, and respiratory. Berger also served as global marketing director of AstraZeneca's Pain, Anesthesia, and Infection Therapy Area, where he was responsible for the therapy area strategy and new product development.
- Five things for pharma marketers to know: Monday, April 24, 2017
- Five things for pharma marketers to know: Tuesday, April 25, 2017
- Drugmakers battle for slice of Humira's billions
- Five things for pharma marketers to know: Wednesday, April 26, 2017
- Five things for pharma marketers to know: Thursday, April 27, 2017
MM&M honors 40 upstarts and veteran innovation gurus.
For the first time MM&M honors a group of 10 agency execs.